← Leaderboards
Bruce A Bunnell
Research Inst Nationwide Children'S Hosp
$8,257,071
Attributed
$9,890,946
Total exposure
43
Grants
36
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,583,485 · 44
By mechanism
P01$5,541,900 · 2
R01$3,805,617 · 3
P51$1,917,314 · 36
R24$1,619,234 · 1
R21$699,420 · 2
Top collaborators
- Stuart B Goodman4 shared
- Hang Lin4 shared
Others in their field
Top investigators on “Grant”
- David R. Weir · University Of Michigan At Ann Arbor$373,949,788
- David Heimbrook · Leidos Biomedical Research, Inc.$341,196,902
- Eric S Lander · Whitehead Institute For Biomedical Res$323,181,457
- Jeffrey P Krischer · University Of South Florida$258,583,867
- Lawrence Corey · Fred Hutchinson Cancer Center$253,286,867
- Barton F Haynes · Duke University$243,251,908
Research focus
GrantCellsFundingResourcesMacaca MulattaAnimalsResearch PersonnelGene TherapyNonhuman PrimateBone MarrowSourceUnited States National Institutes Of HealthAffectPrimatesIn VivoStem CellsTissuesComputer Retrieval Of Information On Scientific Projects DatabaseMesenchymal Stem CellsInstitutionAdipose TissueGloboid Cell LeukodystrophyAnimal ModelPrograms
Grant awards (65)
Defining the unique capacity of the miniature joint model for investigating the role of adipose tissue and its impacts on osteoarthritis$653,310
R01 · FY2025 · AR
Repurposing FDA-approved drugs for the treatment of osteoarthritis using high-throughput screening in microphysiological models$514,092
R01 · FY2025 · AR
Defining the unique capacity of the miniature joint model for investigating the role of adipose tissue and its impacts on osteoarthritis$711,760
R01 · FY2024 · AR
Repurposing FDA-approved drugs for the treatment of osteoarthritis using high-throughput screening in microphysiological models$571,650
R01 · FY2024 · AR
Core Services: Division of Regenerative Medicine, Cell and Tissue Engineering Core$65,399
P51 · FY2019 · OD · contact PI
Scientific Unit: Division of Regenerative Medicine Office of the Chair$40,928
P51 · FY2019 · OD · contact PI
Core Services: Division of Regenerative Medicine, Cell and Tissue Engineering Core$65,399
P51 · FY2018 · OD · contact PI
Scientific Unit: Division of Regenerative Medicine Office of the Chair$40,928
P51 · FY2018 · OD · contact PI
Distinguishing adipose stromal vs. stem cells by serial transplantation$239,198
R21 · FY2013 · DK · contact PI
BIOLOGY OF NON-HUMAN PRIMATE MARROW STROMAL CELLS$57,750
P51 · FY2011 · RR · contact PI
SUBMUCOSAL SIV PERSISTENCE DESPITE HAART$45,135
P51 · FY2011 · RR · contact PI
NONHUMAN PRIMATE MODEL FOR KRABBE'S DISEASE$37,186
P51 · FY2011 · RR · contact PI
STEM CELL PRODUCTION CORE$37,186
P51 · FY2011 · RR · contact PI
IMMUNOPATHOLOGIC ALTERATIONS IN RHESUS MACAQUES WITH GLOBOID CELL LEUKODYSTROPHY$37,186
P51 · FY2011 · RR · contact PI
CNS WHITE MATTER TRACTS AS A NOVEL AVENUE FOR GENE THERAPY FOR KRABBE DISEASE$29,044
P51 · FY2011 · RR · contact PI
Rhesus macaque model of Krabbe disease$373,134
R24 · FY2010 · RR · contact PI
NONHUMAN PRIMATE MODEL FOR KRABBE'S DISEASE$61,801
P51 · FY2010 · RR · contact PI
STEM CELL PRODUCTION CORE: ADULT ANIMAL MARROW STEM CELLS$61,801
P51 · FY2010 · RR · contact PI
IMMUNOPATHOLOGIC ALTERATIONS IN RHESUS MACAQUES WITH GLOBOID CELL LEUKODYSTROPHY$61,801
P51 · FY2010 · RR · contact PI
BIOLOGY OF NON-HUMAN PRIMATE MARROW STROMAL CELLS$61,801
P51 · FY2010 · RR · contact PI
RHESUS SV40 ANTIOXIDANT GENE DELIVERY TO THE CNS$39,400
P51 · FY2010 · RR · contact PI
Homing and Differentiation of Adult Stem Cells to Lung$1,889,552
P01 · FY2009 · HL · contact PI
Adult Stem Cells Mediated Gene Therapy for Cystic Fibrosis$417,263
P01 · FY2009 · HL · contact PI
Rhesus macaque model of Krabbe disease$348,404
R24 · FY2009 · RR · contact PI
Adipose Stem Cell Therapy for Krabbe Disease$161,881
R21 · FY2009 · NS · contact PI
Adipose Stem Cell Therapy for Krabbe Disease$93,125
R21 · FY2009 · NS · contact PI
STEM CELL PRODUCTION CORE: ADULT ANIMAL MARROW STEM CELLS$62,691
P51 · FY2009 · RR · contact PI
IMMUNOPATHOLOGIC ALTERATIONS IN RHESUS MACAQUES WITH GLOBOID CELL LEUKODYSTROPHY$60,105
P51 · FY2009 · RR · contact PI
BIOLOGY OF NON-HUMAN PRIMATE MARROW STROMAL CELLS$60,105
P51 · FY2009 · RR · contact PI
NONHUMAN PRIMATE MODEL FOR KRABBE'S DISEASE$60,105
P51 · FY2009 · RR · contact PI
RHESUS SV40 ANTIOXIDANT GENE DELIVERY TO THE CNS$36,334
P51 · FY2009 · RR · contact PI
MESENCHYMAL STEM CELL THERAPY FOR DIABETES$34,816
P51 · FY2009 · RR · contact PI
Homing and Differentiation of Adult Stem Cells to Lung$1,802,987
P01 · FY2008 · HL · contact PI
Adult Stem Cells Mediated Gene Therapy for Cystic Fibrosis$397,499
P01 · FY2008 · HL · contact PI
Rhesus macaque model of Krabbe disease$321,001
R24 · FY2008 · RR · contact PI
Adipose Stem Cell Therapy for Krabbe Disease$205,216
R21 · FY2008 · NS · contact PI
VECTOR DEVELOPMENT AND PRODUCTION CORE FACILITY$23,958
P51 · FY2008 · RR · contact PI
IMMUNOPATHOLOGIC ALTERATIONS IN RHESUS MACAQUES WITH GLOBOID CELL LEUKODYSTROPHY$23,958
P51 · FY2008 · RR · contact PI
BIOLOGY OF NON-HUMAN PRIMATE MARROW STROMAL CELLS$23,958
P51 · FY2008 · RR · contact PI
NONHUMAN PRIMATE MODEL FOR KRABBE'S DISEASE$23,958
P51 · FY2008 · RR · contact PI
STEM CELL PRODUCTION CORE$23,958
P51 · FY2008 · RR · contact PI
Adult Stem Cells Mediated Gene Therapy for Cystic Fibrosis$348,468
P01 · FY2007 · HL · contact PI
Rhesus macaque model of Krabbe disease$289,868
R24 · FY2007 · RR · contact PI
NONHUMAN PRIMATE MODEL FOR KRABBE'S DISEASE$30,392
P51 · FY2007 · RR · contact PI
BIOLOGY OF NON-HUMAN PRIMATE MARROW STROMAL CELLS$30,391
P51 · FY2007 · RR · contact PI
VECTOR DEVELOPMENT AND PRODUCTION CORE FACILITY$30,391
P51 · FY2007 · RR · contact PI
STEM CELL PRODUCTION CORE$30,391
P51 · FY2007 · RR · contact PI
IN VIVO DIFFERENTIATION AND MIGRATION PROPERTIES OF STEM CELLS$30,391
P51 · FY2007 · RR · contact PI
Adult Stem Cells Mediated Gene Therapy for Cystic Fibrosis$341,923
P01 · FY2006 · HL · contact PI
Rhesus macaque model of Krabbe disease$286,827
R24 · FY2006 · RR · contact PI
VECTOR DEVELOPMENT AND PRODUCTION CORE FACILITY$30,971
P51 · FY2006 · RR · contact PI
STEM CELL PRODUCTION CORE$30,971
P51 · FY2006 · RR · contact PI
IN VIVO DIFFERENTIATION AND MIGRATION PROPERTIES OF STEM CELLS$30,971
P51 · FY2006 · RR · contact PI
Adult Stem Cells Mediated Gene Therapy for Cystic Fibrosis$344,208
P01 · FY2005 · HL
INTRAMARROW GENE TRANSFER IN NEONATAL RHESUS MONKEYS$54,500
P51 · FY2005 · RR
MARROW STROMAL CELL-MEDIATED GENE THERAPY OF KRABBES DISEASE$46,464
P51 · FY2005 · RR
KRABBES DISEASE: MARROW STROMAL GENE THERAPY$47,161
P51 · FY2004 · RR
INTRAMARROW GENE TRANSFER IN NEONATAL RHESUS MONKEYS$47,161
P51 · FY2004 · RR
INTRAMARROW GENE TRANSFER IN NEONATES$344,972
R01 · FY2003 · AI
INTRAMARROW GENE TRANSFER IN NEONATAL RHESUS MONKEYS$185,709
P51 · FY2003 · RR
INTRAMARROW GENE TRANSFER IN NEONATAL RHESUS MONKEYS$61,560
P51 · FY2003 · RR
ANIMAL MODEL OF GLOBOID CELL LEUKODYSTROPHY IN RHESUS MONKEYS$53,199
P51 · FY2003 · RR
INTRAMARROW GENE TRANSFER IN NEONATES$327,456
R01 · FY2002 · AI
INTRAMARROW GENE TRANSFER IN NEONATES$348,093
R01 · FY2001 · AI
INTRAMARROW GENE TRANSFER IN NEONATES$334,284
R01 · FY2000 · AI